Literature DB >> 8058614

Pharmacokinetics of levodopa and carbidopa in rats following different routes of administration.

E Bredberg1, H Lennernäs, L Paalzow.   

Abstract

This study examined the pharmacokinetics of levodopa and carbidopa in the rat after different modes of administration. The drugs were given simultaneously by the intravenous, intraarterial, oral, duodenal, and intraperitoneal routes, as single doses. The ratio of levodopa to carbidopa given was always 4:1. Two iv doses (5 and 15 mg/kg of levodopa) were given to test for nonlinearity. Three ip doses of levodopa were given (5, 7.5, and 15 mg/kg), and the 15 mg/kg dose was given in three volumes (2, 4, and 20 mL/kg). One oral dose and two intraduodenal doses of 15 mg/kg were given. The drugs were dissolved in saline in one of the intraduodenal doses and suspended in 1.8% methylcellulose in the other. The elimination of levodopa was nonlinear. There was a comparatively high degree of interindividual variability in absorption with the oral route, but this was substantially reduced when levodopa was given intraduodenally. There was also much less variability with the intraperitoneal route compared to the oral, and the degree of absorption was generally high. There was a significantly higher extent and slower rate of absorption when levodopa was administered ip in a large volume of vehicle. These results suggest that the oral route may not be the optimal method of delivering levodopa to patients who have a fluctuating response and that a continuous delivery system via the intraperitoneal or intraduodenal routes might be a better alternative.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058614     DOI: 10.1023/a:1018970617104

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier.

Authors:  L A Wade; R Katzman
Journal:  J Neurochem       Date:  1975-12       Impact factor: 5.372

2.  Pharmacokinetics and effects of levodopa in advanced Parkinson's disease.

Authors:  E Bredberg; J Tedroff; S M Aquilonius; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.

Authors:  R Kurlan; A J Rubin; C Miller; L Rivera-Calimlim; A Clarke; I Shoulson
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

4.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

5.  Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.

Authors:  R D Sweet; F H McDowell
Journal:  Neurology       Date:  1974-10       Impact factor: 9.910

6.  The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.

Authors:  R J Hardie; S L Malcolm; A J Lees; G M Stern; J G Allen
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

7.  Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility.

Authors:  R Kurlan; K P Rothfield; W R Woodward; J G Nutt; C Miller; D Lichter; I Shoulson
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

8.  Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.

Authors:  J I Sage; L Schuh; R E Heikkila; R C Duvoisin
Journal:  Clin Neuropharmacol       Date:  1988-02       Impact factor: 1.592

9.  Carbidopa dosage modifies L-dopa induced side effects and blood levels of L-dopa and other amino acids in advanced parkinsonism.

Authors:  F Bermejo Pareja; P Martinez-Martin; V Muradas; J G de Yébenes
Journal:  Acta Neurol Scand       Date:  1985-11       Impact factor: 3.209

10.  Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients.

Authors:  J G Nutt; W R Woodward
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

View more
  12 in total

1.  Administration of substances to laboratory animals: routes of administration and factors to consider.

Authors:  Patricia V Turner; Thea Brabb; Cynthia Pekow; Mary Ann Vasbinder
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.

Authors:  O K Sujith; Carol Lane
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

3.  Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats.

Authors:  L Wang; N P Murphy; A Stengel; M Goebel-Stengel; D H St Pierre; N T Maidment; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-03-23       Impact factor: 3.598

4.  Effects of aging and levodopa on the laryngeal adductor reflex in rats.

Authors:  Xin Feng; Zengrui Xu; Susan G Butler; Iris Leng; Tan Zhang; Stephen B Kritchevsky
Journal:  Exp Gerontol       Date:  2012-07-21       Impact factor: 4.032

5.  Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.

Authors:  Lixin Wang; Sachiko Mogami; Hiroshi Karasawa; Chihiro Yamada; Seiichi Yakabi; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  Peptides       Date:  2014-03-11       Impact factor: 3.750

6.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

Review 7.  Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies?

Authors:  Abdullah Al Shoyaib; Sabrina Rahman Archie; Vardan T Karamyan
Journal:  Pharm Res       Date:  2019-12-23       Impact factor: 4.200

8.  A pharmacokinetic model to predict the PK interaction of L-dopa and benserazide in rats.

Authors:  S Grange; N H Holford; T W Guentert
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

9.  In vivo antiplasmodial activities and acute toxicity assessment of two plant cocktail extracts commonly used among Southwestern Nigerians.

Authors:  Rachel Omagha; Emmanuel Taiwo Idowu; Chibuisi Gideon Alimba; Olubunmi Adetoro Otubanjo; Wellington Aghoghovwia Oyibo; Esther Oluwatoyin Agbaje
Journal:  J Parasit Dis       Date:  2021-09-14

10.  Behavioral intoxication following voluntary oral ingestion of tetramethylenedisulfotetramine: Dose-dependent onset, severity, survival, and recovery.

Authors:  Nathaniel C Rice; Noah A Rauscher; Jeffrey L Langston; Todd M Myers
Journal:  Neurotoxicology       Date:  2017-09-07       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.